Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Diabetes Care|June 30, 2022
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V PopulationGiulia Ferrannini, Dirk De Bacquer, Iris Erlund, et al.
Diabetes Care|September 2, 2019
Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI TrialThomas Nyström, Stefan K James, Bertil Lindahl, et al.
Cardiovascular Diabetology|September 3, 2024
Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational studyBashaaer Sharad, Nils Eckerdal, Martin Magnusson, et al.
Plos One|December 3, 2014
Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controlsAbdul-Aleem Mohammad, Afsar Rahbar, Weng-Onn Lui, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
Heart (British Cardiac Society)|March 13, 2021
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary interventionDimitrios Venetsanos, Erik Träff, David Erlinge, et al.
Circulation. Cardiovascular Interventions|October 1, 2021
Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty RegistryJuliane Jurga, Karolina Elizabeth Szummer, Christian Lewinter, et al.
European Journal of Preventive Cardiology|August 29, 2025
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease Results from the combined EUROASPIRE IV and V studiesSafi Moayad Al-Azzawy, Mark Coyle, Guy De Backer, et al.
American Heart Journal|May 9, 2025
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trialStefan James, Andreas Dyreborg Christoffersen, Jens-Peter David, et al.
Atherosclerosis|May 1, 2026
Lipoprotein(a) cascade screening in coronary artery diseaseKarin Littmann, Daniel Eriksson Hogling, Mustafa Suhel, et al.
Pageof 7